Comparative evaluation of the application of hepatoprotector LIV-52 and prebiotic Rekicen-RD in preventive correction of experimental NSAID-hepatopathywith Nimesulide-Reference-Cited by-同舟云学术

Comparative evaluation of the application of hepatoprotector LIV-52 and prebiotic Rekicen-RD in preventive correction of experimental NSAID-hepatopathywith Nimesulide

Published:2020-06-25 Issue:4 Volume:174 Page:115-120
ISSN:1682-8658
Container-title:Experimental and Clinical Gastroenterology
language:
Short-container-title:jour

Author:

Lazarenko L. V.¹^ORCID,Kosareva P. V.²^ORCID

Affiliation:

1. Perm Institute of the Federal Penal Service

2. Perm State National Research University

Publisher

LLC Global Media Technology

Subject

Gastroenterology,Hepatology

Reference21 articles.

1. Lazebnik L. B., Golovanova E. V., Alekseenko S. A. et al. Recommendations for the prevention and treatment of esophago-gastro-entero-colopathy induced by nonsteroidal antiinflammatory drugs “nsaid”. Experimental and Clinical Gastroenterology. 2018;151(03):04–18.

2. Zholobova E. S., Konopelko O. Yu., Gesheva Z. V. Gepatotoksichnost nesteroidnyih protivovospalitelnyih preparatov, primenyaemyih v detskoy revmatologii [Hepatotoxicity of non-steroid anti-inf lammatory drugs used in child rheumatology]. Pediatrics. 2009; 88(5):155–160.

3. Walker A. M. Quantitative studies of the risk of serious hepatic injury in persons using nonsteroidal antiinflammatory drugs. Arthritis Rheum. 1997;40:201–208.

4. Greaves R. R. Agarwal A., Patch D. et al. Inadvertent diclofenac rechallenge from generic and non-generic prescribing, leading to liver transplantation for fulminant liver failure. Eur. J. Gastroenterol. Hepatol. 2001;13:71–73.

5. O’Connor N., Dargan P. I., Jones A. L. Hepatocellular damage from non-steroidal anti-infl ammatory drugs. Q. J. Med. 2003;96:787–791.